Vident Investment Advisory, LLC Novartis Ag Transaction History

Vident Investment Advisory, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $138,224 - $156,735	1,494 Added 19.2%	9,277 $936,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $80,030 - $92,810	1,000 Added 14.74%	7,783 $716,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $512,455 - $627,563	6,783 New	6,783 $615,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $197,112 - $229,500	2,448 New	2,448 $208,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $2.28 Million - $2.54 Million	-30,996 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $145,125 - $167,868	-2,168 Reduced 6.54%	30,996 $2.67 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $795,991 - $899,613	12,263 Added 58.67%	33,164 $2.51 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $430,786 - $514,998	6,120 Added 41.4%	20,901 $1.7 Million
Q4 2017 Feb 15, 2018	BUY	$72.33 - $77.64 $26,979 - $28,959	373 Added 2.59%	14,781 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $1.07 Million - $1.11 Million	14,408	14,408 $1.24 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.